GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (BSP:ABTT34) » Definitions » Beneish M-Score

Abbott Laboratories (BSP:ABTT34) Beneish M-Score : -2.56 (As of Apr. 26, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Abbott Laboratories Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.56 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Abbott Laboratories's Beneish M-Score or its related term are showing as below:

BSP:ABTT34' s Beneish M-Score Range Over the Past 10 Years
Min: -2.8   Med: -2.59   Max: -2.3
Current: -2.56

During the past 13 years, the highest Beneish M-Score of Abbott Laboratories was -2.30. The lowest was -2.80. And the median was -2.59.


Abbott Laboratories Beneish M-Score Historical Data

The historical data trend for Abbott Laboratories's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Beneish M-Score Chart

Abbott Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.58 -2.59 -2.64 -2.66 -2.56

Abbott Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.82 -2.75 -2.58 -2.56 -

Competitive Comparison of Abbott Laboratories's Beneish M-Score

For the Medical Devices subindustry, Abbott Laboratories's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Beneish M-Score falls into.



Abbott Laboratories Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Abbott Laboratories for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0397+0.528 * 1.0169+0.404 * 1.0253+0.892 * 0.8924+0.115 * 1.0555
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0581+4.679 * -0.026989-0.327 * 0.9325
=-2.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was R$43,221 Mil.
Revenue was 50178.852 + 50093.234 + 48430.219 + 50768.224 = R$199,471 Mil.
Gross Profit was 27855.363 + 27350.521 + 26671.082 + 28209.778 = R$110,087 Mil.
Total Current Assets was R$111,078 Mil.
Total Assets was R$358,734 Mil.
Property, Plant and Equipment(Net PPE) was R$49,753 Mil.
Depreciation, Depletion and Amortization(DDA) was R$16,134 Mil.
Selling, General, & Admin. Expense(SGA) was R$54,480 Mil.
Total Current Liabilities was R$67,818 Mil.
Long-Term Debt & Capital Lease Obligation was R$71,282 Mil.
Net Income was 7810.281 + 7091.973 + 6673.838 + 6864.935 = R$28,441 Mil.
Non Operating Income was 416.483 + 459.299 + 752.324 + 546.903 = R$2,175 Mil.
Cash Flow from Operations was 14885.592 + 9269.94 + 5839.001 + 5953.43 = R$35,948 Mil.
Total Receivables was R$46,584 Mil.
Revenue was 52931.331 + 54585.876 + 56821.959 + 59194.278 = R$223,533 Mil.
Gross Profit was 28839.209 + 30313.252 + 31921.655 + 34376.971 = R$125,451 Mil.
Total Current Assets was R$132,310 Mil.
Total Assets was R$390,457 Mil.
Property, Plant and Equipment(Net PPE) was R$48,058 Mil.
Depreciation, Depletion and Amortization(DDA) was R$16,751 Mil.
Selling, General, & Admin. Expense(SGA) was R$57,701 Mil.
Total Current Liabilities was R$81,246 Mil.
Long-Term Debt & Capital Lease Obligation was R$81,120 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(43221.136 / 199470.529) / (46584.397 / 223533.444)
=0.216679 / 0.2084
=1.0397

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(125451.087 / 223533.444) / (110086.744 / 199470.529)
=0.561218 / 0.551895
=1.0169

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (111078.466 + 49752.569) / 358733.957) / (1 - (132309.97 + 48058.355) / 390457.085)
=0.55167 / 0.538059
=1.0253

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=199470.529 / 223533.444
=0.8924

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(16751.358 / (16751.358 + 48058.355)) / (16134.118 / (16134.118 + 49752.569))
=0.25847 / 0.244877
=1.0555

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(54480.426 / 199470.529) / (57700.582 / 223533.444)
=0.273125 / 0.25813
=1.0581

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((71282.29 + 67818.132) / 358733.957) / ((81120.111 + 81246.001) / 390457.085)
=0.387754 / 0.415836
=0.9325

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(28441.027 - 2175.009 - 35947.963) / 358733.957
=-0.026989

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Abbott Laboratories has a M-score of -2.63 suggests that the company is unlikely to be a manipulator.


Abbott Laboratories Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (BSP:ABTT34) Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Abbott Laboratories (BSP:ABTT34) Headlines

No Headlines